Report DMCA A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic viru
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.